Valeant Pharmaceuticals reported $521M in Trade Creditors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Ani Pharmaceuticals ANIP:US USD 29.3M 10.31M
Aurora Cannabis Inc ACB:CN CAD 16.37M 1.84M
Biogen BIIB:US USD 491.5M 108.3M
Canopy Growth Corp WEED:CN CAD 63.14M 5.06M
Catalent CTLT:US USD 367M 12M
Corcept Therapeutics CORT:US USD 11.98M 3.8M
Danaher DHR:US USD 2.3B 105M
Drreddys Laboratories RDY:US INR 26.02B 3.24B
Endo International Ordinary Shares ENDP:US USD 85M 5.64M
Horizon Pharma HZNP:US USD 155.8M 123.69M
Lannett LCI:US USD 33.16M 9.1M
Nektar Therapeutics NKTR:US USD 12.98M 7.65M
Pacira Pharmaceuticals PCRX:US USD 15.22M 2.29M
Perrigo Ordinary Shares PRGO:US USD 537.3M 75.9M
Phibro Animal Health PAHC:US USD 80.49M 7.89M
Prestige Brands PBH:US USD 64.25M 8.06M
Revance Therapeutics RVNC:US USD 4.55M 3.8M
Supernus Pharmaceuticals SUPN:US USD 10.54M 5.47M
Valeant Pharmaceuticals VRX:CN USD 521M 35M
Zoetis ZTS:US USD 405M 32M